in vitro fertilization

Women who pursue in vitro fertilization (IVF) to become pregnant are more likely to give birth if they have health insurance that covers the procedure, according to new research at the School of Medicine. The key reason is financial rather than medical: The high cost for one procedure prohibits many women from seeking a second if the first attempt fails.

Emily Jungheim, MD, at Washington University School of Medicine in St. Louis, is studying how insurance coverage and mandates influence ART practice patterns and outcomes.

In vitro fertilization can cost anywhere from $10,000 – $15,000 for each round of treatments. This means access to assisted reproductive technologies (ART) is generally limited to a relatively small portion of couples that seek it. Several state governments have turned to public policy in an attempt to make access to ART more widely available. But two professors from the Olin School of Business at Washington University in St. Louis find that market competition can be as effective at expanding access as requiring insurance companies to cover infertility treatments. At the same time, competition appears to lower the rate of high-risk births and encourages the use of new technologies.